Lanean...

MBRS-12. INTERFERENCE WITH THE FUNCTION OF MYC IN GROUP 3 MEDULLOBLASTOMA

High-risk medulloblastoma (MB) is a deadly disease with poor overall survival. Survivors suffer from severe treatment-associated morbidity. Patients with Group 3 MB with an amplification of MYC show particularly poor outcome. Therefore novel therapies tailored to this subgroup are urgently needed. W...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Ecker, Jonas, Thatikonda, Venu, Oehme, Ina, Valinciute, Gintvile, Selt, Florian, Buhl, Juliane L, Usta, Diren, van Tilburg, Cornelis M, Herold-Mende, Christel, Schnölzer, Martina, Warnken, Uwe, Kool, Marcel, Jäger, Natalie, Pfister, Stefan M, Witt, Olaf, Milde, Till
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012712/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.457
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!